advertisement

Topcon

Oeverhaus U 1

Showing records 1 to 1 | Display all abstracts from Oeverhaus U

11691 Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies
Bayer A; Weiler W; Oeverhaus U; Skrotzki F-E; Stewart WC
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 470-478

Issue 7-1

Change Issue


advertisement

Oculus